Cargando…
Low Levels of Antibody-Dependent Enhancement in Vitro Using Viruses and Plasma from Dengue Patients
BACKGROUND: The majority of dengue patients infected with any serotype of dengue virus (DENV) are asymptomatic, but the remainder may develop a wide spectrum of clinical symptoms, ranging from mild dengue fever (DF) to severe dengue hemorrhagic fever (DHF). Severe cases occur more often in patients...
Autores principales: | Chaichana, Panjaporn, Okabayashi, Tamaki, Puiprom, Orapim, Sasayama, Mikiko, Sasaki, Tadahiro, Yamashita, Akifumi, Ramasoota, Pongrama, Kurosu, Takeshi, Ikuta, Kazuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958444/ https://www.ncbi.nlm.nih.gov/pubmed/24642752 http://dx.doi.org/10.1371/journal.pone.0092173 |
Ejemplares similares
-
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
por: Pipattanaboon, Chonlatip, et al.
Publicado: (2013) -
Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
por: Noda, Megumi, et al.
Publicado: (2012) -
Chikungunya virus was isolated in Thailand, 2010
por: Sasayama, Mikiko, et al.
Publicado: (2014) -
Chimeric flavivirus enables evaluation of antibodies against dengue virus envelope protein in vitro and in vivo
por: Kurosu, Takeshi, et al.
Publicado: (2020) -
An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
por: Kotaki, Tomohiro, et al.
Publicado: (2021)